These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 30507707)

  • 21. APOL1 risk genotype in Europe: Data in patients with focal segmental glomerulosclerosis and after renal transplantation.
    Servais A; Gribouval O; Gaillard F; Antignac C
    Nephrol Ther; 2019 Apr; 15 Suppl 1():S85-S89. PubMed ID: 30981401
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical Genetic Testing for APOL1: Are we There Yet?
    Young BA; Fullerton SM; Wilson JG; Cavanaugh K; Blacksher E; Spigner C; Himmelfarb J; Burke W
    Semin Nephrol; 2017 Nov; 37(6):552-557. PubMed ID: 29110763
    [TBL] [Abstract][Full Text] [Related]  

  • 23. APOL1-Associated Nephropathy: A Key Contributor to Racial Disparities in CKD.
    Freedman BI; Limou S; Ma L; Kopp JB
    Am J Kidney Dis; 2018 Nov; 72(5 Suppl 1):S8-S16. PubMed ID: 30343724
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Kidney Disease Progression in Membranous Nephropathy among Black Participants with High-Risk APOL1 Genotype.
    Chen DP; Henderson CD; Anguiano J; Aiello CP; Collie MM; Moreno V; Hu Y; Hogan SL; Falk RJ;
    Clin J Am Soc Nephrol; 2023 Mar; 18(3):337-343. PubMed ID: 36763808
    [TBL] [Abstract][Full Text] [Related]  

  • 25. APOL1 Genotyping in Potential African American Living Kidney Donors: Utility and Cost-Effectiveness.
    Gudsoorkar P; Anand M; Abu Jawdeh BG
    Am J Nephrol; 2020; 51(2):116-118. PubMed ID: 31940609
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ten years in: APOL1 reaches beyond the kidney.
    Waitzman JS; Lin J
    Curr Opin Nephrol Hypertens; 2019 Jul; 28(4):375-382. PubMed ID: 31082862
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Optimal management of HIV- positive adults at risk for kidney disease in Nigeria (Renal Risk Reduction "R3" Trial): protocol and study design.
    Aliyu MH; Wudil UJ; Ingles DJ; Shepherd BE; Gong W; Musa BM; Muhammad H; Sani MU; Abdu A; Nalado AM; Atanda A; Ahonkhai AA; Ikizler TA; Winkler CA; Kopp JB; Kimmel PL; Wester CW
    Trials; 2019 Jun; 20(1):341. PubMed ID: 31182139
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genome-wide association studies suggest that APOL1-environment interactions more likely trigger kidney disease in African Americans with nondiabetic nephropathy than strong APOL1-second gene interactions.
    Langefeld CD; Comeau ME; Ng MCY; Guan M; Dimitrov L; Mudgal P; Spainhour MH; Julian BA; Edberg JC; Croker JA; Divers J; Hicks PJ; Bowden DW; Chan GC; Ma L; Palmer ND; Kimberly RP; Freedman BI
    Kidney Int; 2018 Sep; 94(3):599-607. PubMed ID: 29885931
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cases in Precision Medicine: APOL1 and Genetic Testing in the Evaluation of Chronic Kidney Disease and Potential Transplant.
    Neugut YD; Mohan S; Gharavi AG; Kiryluk K
    Ann Intern Med; 2019 Nov; 171(9):659-664. PubMed ID: 31590185
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Host factors predisposing to kidney disease in people with HIV.
    Hung RKY; Winkler CA; Post FA
    Curr Opin HIV AIDS; 2023 Mar; 18(2):87-92. PubMed ID: 36722197
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Joint Associations of Maternal-Fetal APOL1 Genotypes and Maternal Country of Origin With Preeclampsia Risk.
    Hong X; Rosenberg AZ; Zhang B; Binns-Roemer E; David V; Lv Y; Hjorten RC; Reidy KJ; Chen TK; Wang G; Ji Y; Simpson CL; Davis RL; Kopp JB; Wang X; Winkler CA
    Am J Kidney Dis; 2021 Jun; 77(6):879-888.e1. PubMed ID: 33359152
    [TBL] [Abstract][Full Text] [Related]  

  • 32. APOL1-Associated End-Stage Renal Disease in a Living Kidney Transplant Donor.
    Zwang NA; Shetty A; Sustento-Reodica N; Gordon EJ; Leventhal J; Gallon L; Friedewald JJ
    Am J Transplant; 2016 Dec; 16(12):3568-3572. PubMed ID: 27588375
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recipient APOL1 risk alleles associate with death-censored renal allograft survival and rejection episodes.
    Zhang Z; Sun Z; Fu J; Lin Q; Banu K; Chauhan K; Planoutene M; Wei C; Salem F; Yi Z; Liu R; Cravedi P; Cheng H; Hao K; O'Connell PJ; Ishibe S; Zhang W; Coca SG; Gibson IW; Colvin RB; He JC; Heeger PS; Murphy B; Menon MC
    J Clin Invest; 2021 Nov; 131(22):. PubMed ID: 34499625
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The evolving science of apolipoprotein-L1 and kidney disease.
    Chen TK; Estrella MM; Parekh RS
    Curr Opin Nephrol Hypertens; 2016 May; 25(3):217-25. PubMed ID: 27023839
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Integrating APOL1 Gene Variants Into Renal Transplantation: Considerations Arising From the American Society of Transplantation Expert Conference.
    Newell KA; Formica RN; Gill JS; Schold JD; Allan JS; Covington SH; Wiseman AC; Chandraker A
    Am J Transplant; 2017 Apr; 17(4):901-911. PubMed ID: 27997071
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of Recipient APOL1 Kidney Risk Alleles With Kidney Transplant Outcomes.
    Roy N; Morales-Alvarez MC; Anis KH; Goral S; Doria C; Kopp JB; Winkler CA; Feng R; Rosas SE
    Transplantation; 2023 Dec; 107(12):2575-2580. PubMed ID: 37527489
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A focus on the association of Apol1 with kidney disease in children.
    Ekulu PM; Nkoy AB; Adebayo OC; Kazadi OK; Aloni MN; Arcolino FO; Ngiyulu RM; Gini JE; Lepira FB; Van den Heuvel LP; Levtchenko EN
    Pediatr Nephrol; 2021 Apr; 36(4):777-788. PubMed ID: 32253519
    [TBL] [Abstract][Full Text] [Related]  

  • 38. COVID-19-Associated Glomerular Disease.
    Shetty AA; Tawhari I; Safar-Boueri L; Seif N; Alahmadi A; Gargiulo R; Aggarwal V; Usman I; Kisselev S; Gharavi AG; Kanwar Y; Quaggin SE
    J Am Soc Nephrol; 2021 Jan; 32(1):33-40. PubMed ID: 33214201
    [TBL] [Abstract][Full Text] [Related]  

  • 39. APOL1 renal risk variants exacerbate podocyte injury by increasing inflammatory stress.
    Wakashin H; Heymann J; Roshanravan H; Daneshpajouhnejad P; Rosenberg A; Shin MK; Hoek M; Kopp JB
    BMC Nephrol; 2020 Aug; 21(1):371. PubMed ID: 32854642
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Apoprotein L1 risk variants and kidney transplantation: a protocol for systematic review and meta-analysis.
    Alao MA; Raji YR; Asinobi O; Akinboro AO; Ngene SO; Olayinka IR; Okoye I; Nna E
    Pan Afr Med J; 2022; 42():77. PubMed ID: 36034035
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.